Update News.md

docs/News.md

@@ -1,3 +1,19 @@
+## December 18, 2024
+*   **Added data** consisting of 34,904 samples from 9 studies:
+    * [MSK-CHORD (MSK, Nature 2024)](https://www.cbioportal.org/study/summary?id=msk_chord_2024) *25040 samples*
+    * [MSK ctDNA Sequencing Cohort (MSK, Nature Med 2024)](https://www.cbioportal.org/study/summary?id=msk_ctdna_vte_2024) *5567 samples*
+    * [Prostate Cancer (MSK, Clin Cancer Res 2024)](https://www.cbioportal.org/study/summary?id=prostate_msk_2024) *2260 samples*
+	* [Hepatocellular Carcinoma (MSK, Clin Cancer Res 2024)](https://www.cbioportal.org/study/summary?id=hcc_msk_2024) *1370 samples*
+    * [Pancreatic Cancer (MSK, Cancer Cell 2024)](https://www.cbioportal.org/study/summary?id=pancreas_msk_2024) *395 samples*
+    * [Metastatic Pancreatic Neuroendocrine Tumor (MSK, JCO Precis Oncol 2018)](https://www.cbioportal.org/study/summary?id=panet_msk_2018) *96 samples*
+    * [Recurrent CNS Lymphoma - Ibrutinib Long Term Follow Up (MSK, Cancer Cell 2024)](https://www.cbioportal.org/study/summary?id=pcnsl_msk_2024) *86 samples*
+    * [Metastatic Breast Cancer (DFCI, Cancer Discovery 2020)](https://www.cbioportal.org/study/summary?id=brca_dfci_2020) *59 samples*
+    * [Atypical Small Cell Lung Cancer (MSK, Cancer Discovery 2024)](https://www.cbioportal.org/study/summary?id=asclc_msk_2024) *31 samples*
+
+*   **Data Improvement**
+
+    * Pan-can studies TBL score addition: Tumor Break Load (TBL) score is added to all 32 TCGA Pan-Can studies,to clinical sample data file. Data source: [Lakbir et al., Eur J Cancer 2024](https://pubmed.ncbi.nlm.nih.gov/36334560/)
+
 ## December 11, 2024
 *   **Added data** consisting of 5,567 samples from 6 TARGET studies from the [Genomic Data Commons (GDC)](https://gdc.cancer.gov) as part of the [Cancer Research Data Commons (NCI-CRDC)](https://datacommons.cancer.gov) initiative.
     * [Acute Myeloid Leukemia (TARGET, GDC)](https://www.cbioportal.org/study/summary?id=aml_target_gdc) *2482 samples*